BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29575012)

  • 1. High expression of glutamate-ammonia ligase is associated with unfavorable prognosis in patients with ovarian cancer.
    Fan S; Wang Y; Zhang Z; Lu J; Wu Z; Shan Q; Sun C; Wu D; Li M; Sheng N; Xie Y; Zheng Y
    J Cell Biochem; 2018 Jul; 119(7):6008-6015. PubMed ID: 29575012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUL Promotes Cell Proliferation in Breast Cancer.
    Wang Y; Fan S; Lu J; Zhang Z; Wu D; Wu Z; Zheng Y
    J Cell Biochem; 2017 Aug; 118(8):2018-2025. PubMed ID: 27791265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic values of matrix metalloproteinases in ovarian cancer.
    Zeng L; Qian J; Zhu F; Wu F; Zhao H; Zhu H
    J Int Med Res; 2020 Jan; 48(1):300060519825983. PubMed ID: 31099295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients.
    Chen YL; Chou CY; Chang MC; Lin HW; Huang CT; Hsieh SF; Chen CA; Cheng WF
    Endocr Relat Cancer; 2015 Oct; 22(5):703-11. PubMed ID: 26150382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA8 is a prognostic marker for epithelial ovarian cancer.
    Liu X; Xu Y; Jin Q; Wang W; Zhang S; Wang X; Zhang Y; Xu X; Huang J
    Oncotarget; 2016 Apr; 7(15):20801-9. PubMed ID: 26989075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of N-acetylglucosaminyltransferase V in mucinous tumors of the ovary.
    Takahashi N; Yamamoto E; Ino K; Miyoshi E; Nagasaka T; Kajiyama H; Shibata K; Nawa A; Kikkawa F
    Oncol Rep; 2009 Nov; 22(5):1027-32. PubMed ID: 19787216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
    Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer.
    Innamaa A; Jackson L; Asher V; van Schalkwyk G; Warren A; Keightley A; Hay D; Bali A; Sowter H; Khan R
    Clin Transl Oncol; 2013 Nov; 15(11):910-8. PubMed ID: 23479219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy.
    Xu Z; Tang H; Zhang T; Sun M; Han Q; Xu J; Wei M; Yu Z
    Life Sci; 2020 Jan; 241():117171. PubMed ID: 31843525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-140-5p suppresses invasion and proliferation of glioma cells by targeting glutamate-ammonia ligase (GLUL).
    Zhang R; Zhu JC; Hu H; Lin QY; Shao W; Ji TH
    Neoplasma; 2020 Mar; 67(2):371-378. PubMed ID: 31986891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
    Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
    Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.
    Sung PL; Jan YH; Lin SC; Huang CC; Lin H; Wen KC; Chao KC; Lai CR; Wang PH; Chuang CM; Wu HH; Twu NF; Yen MS; Hsiao M; Huang CY
    Oncotarget; 2016 Jan; 7(4):4036-47. PubMed ID: 26716408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
    Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
    Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.
    Liu P; Sun YL; Du J; Hou XS; Meng H
    Int J Gynecol Cancer; 2012 May; 22(4):586-92. PubMed ID: 22266931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer.
    Katso RM; Manek S; Biddolph S; Whittaker R; Charnock MF; Wells M; Ganesan TS
    Cancer Res; 1999 May; 59(10):2265-70. PubMed ID: 10344726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of salusin-β is associated with poor prognosis in ovarian cancer.
    Zhang Q; Chen WM; Zhang XX; Zhang HX; Wang HC; Zheng FY; Zhu FF
    Oncol Rep; 2017 Mar; 37(3):1826-1832. PubMed ID: 28184918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
    McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
    Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
    Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
    Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.